<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=28853"><dc:title>Prevalence, genetic variants, and clinical implications of hypocholesterolemia in children</dc:title><dc:creator>Grošelj,	Urh	(Avtor)
	</dc:creator><dc:creator>Kafol,	Jan	(Avtor)
	</dc:creator><dc:creator>Molk,	Neža	(Avtor)
	</dc:creator><dc:creator>Sedej,	Katarina	(Avtor)
	</dc:creator><dc:creator>Mlinarič,	Matej	(Avtor)
	</dc:creator><dc:creator>Šikonja,	Jaka	(Avtor)
	</dc:creator><dc:creator>Šuštar,	Urša	(Avtor)
	</dc:creator><dc:creator>Čugalj Kern,	Barbara	(Avtor)
	</dc:creator><dc:creator>Kovač,	Jernej	(Avtor)
	</dc:creator><dc:creator>Battelino,	Tadej	(Avtor)
	</dc:creator><dc:creator>Debeljak,	Maruša	(Avtor)
	</dc:creator><dc:subject>APOB</dc:subject><dc:subject>children</dc:subject><dc:subject>hypocholesterolemia</dc:subject><dc:subject>next-generation sequencing</dc:subject><dc:subject>prevalence</dc:subject><dc:description>Background and aims: In contrast to extensively studied hypercholesterolemia, knowledge of hypocholesterolemia is limited. This study aims to assess the prevalence, clinical characteristics, and genetics of children and adolescents with hypocholesterolemia. Methods: This national prospective cross-sectional cohort study was part of Slovenia's universal opt-out cholesterol screening program. The first part assessed hypocholesterolemia prevalence among 3538 children aged 5 years, randomly selected at the mandatory check-up. The second part included analysis of demographic and clinical data and genetic testing of 71 individuals with suspected hypocholesterolemia (total cholesterol [TC] &lt; 3.0 mmol/L [116.0 mg/dL]) referred to the Lipid Clinic of University Children's Hospital Ljubljana. Results: The prevalence of hypocholesterolemia among 3538 children was 2.66 % (95 % CI: 2.13-3.19 %). Among the 71 genetically tested individuals with suspected hypocholesterolemia, those with pathogenic variants had lower TC (2.58 ± 0.44 mmol/L vs. 2.85 ± 0.42 mmol/L [99.77 ± 17.02 mg/dL vs. 110.20 ± 16.24 mg/dL]; p = 0.037) and low-density lipoprotein cholesterol (1.00 ± 0.40 mmol/L vs. 1.33 ± 0.40 mmol/L [38.67 ± 15.47 mg/dL vs. 51.43 ± 15.47 mg/dL]; p = 0.014) compared to those without such variants. Genetic testing identified pathogenic alterations in 15 subjects, including 4 novel loss-of-function variants in the APOB gene. All but one subject were asymptomatic. Conclusions: This study provides new clinical and genetic insights into hypocholesterolemia. Asymptomatic patients with hypocholesterolemia may not require further evaluation, but additional research is needed to understand hypocholesterolemia better.</dc:description><dc:date>2025</dc:date><dc:date>2026-04-09 13:05:05</dc:date><dc:type>Neznano</dc:type><dc:identifier>28853</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
